FDA OKs Targeted Lung Cancer Rx
The US Food and Drug Administration (FDA) has approved a targeted drug for a type of non-small cell lung cancer.
A Drop in Lung Cancer Deaths
Deaths from the most common type of lung cancer have decreased rapidly in recent years. Researchers are saying new treatments are behind this good news.
FDA Approved Treatment Option - Non Small Cell Lung Cancer
An Approved Treatment Option For Previously Treated Advanced NSCLC. Learn More.